BioCentury
ARTICLE | Financial News

Peloton races to $18M A round

July 28, 2011 12:31 AM UTC

Cancer company Peloton Therapeutics Inc. (Dallas, Texas) raised $18 million in a series A round led by The Column Group. Remeditex Ventures and individual investor Peter O'Donnell Jr. participated. Peloton in-licensed three early-stage small molecule cancer programs from the University of Texas Southwestern Medical Center. The company would not disclose details about the programs. Last year, Peloton received an $11 million grant from the Cancer Prevention and Research Institute of Texas (CPRIT). ...